Skip to content
Multidisciplinary Association for Psychedelic Studies – MAPS

Multidisciplinary Association for Psychedelic Studies - MAPS

  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
  • Our Work
    • Psychedelic Fundamentals
    • MAPS Public Benefit Corp
    • MDMA Therapy Training
    • Zendo Project
    • Policy & Advocacy
    • Health Equity
  • Our Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • Donate
    • Host a Party
    • Participate in Trial
    • Volunteer
    • Events
    • Resources
  • Store
    • Learning
    • Apparel
    • Accessories
    • Bookshop
    • 7 Principles
Login
  • Donate
0

Newsletter: March 2022

Michael Mullette Joins MAPS PBC Senior Leadership as Chief Operating Officer

March 29, 2022

On March 8, MAPS Public Benefit Corporation (MAPS PBC) announced that Michael Mullette, an experienced drug development and commercialization expert, has joined its senior leadership team as Chief Operating Officer. Mullette most recently served as the Vice President and Managing Director of North America for Moderna, where he oversaw commercialization of the company’s COVID-19 vaccine during the height of the pandemic.

Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. Prior to his work at Moderna, Mullette developed broad pharmaceutical expertise with Sanofi in a variety of management roles in the U.S., Australia, France, Japan, and Canada. He holds a B.S. in Marketing from Villanova University, and an M.B.A. from Lehigh University. We are thrilled to have Michael’s expertise guiding the development of MDMA-assisted therapy for PTSD! Read our full statement here.

Results for Phase 1 Randomized Controlled Trial of MDMA and Fear Extinction Retention in Healthy Adults Published in Psychopharmacology
On February 15, 2022, the results of the MAPS-sponsored study by Barbara Rothbaum and team  evaluating MDMA on the startle response in healthy adults was published in the medical journal Psychopharmacology. This randomized, blinded, placebo-controlled Phase 1 mechanism of action study investigated the effects of MDMA on startle testing learning in healthy volunteers in comparison to a placebo control. Visit the study’s webpage to learn more and view a timeline of the study’s history.

Journal of Psychiatric Research Publishes Results of Eating Behavior from Multi-Site Phase 3 Study of MDMA-Assisted Therapy for PTSD (MAPP1)
An analysis of eating behavior in study participants undergoing treatment in our Phase 3 study of MDMA-assisted therapy for PTSD was published in the Journal of Psychiatric Research on March 10, 2022. Eating disorders are common in individuals with PTSD, and MDMA-assisted therapy significantly reduced eating disorder symptoms compared to therapy with a placebo among participants with severe PTSD.

Refer Talent to MAPS to Win Prizes
You could win prizes for referring a friend to MAPS, MAPS Public Benefit Corporation (MAPS PBC), and MAPS Europe for one of over 30 open job opportunities! For each candidate you refer before April 1, you’ll be entered into a drawing to win prizes including a MAPS swag pack and an invitation to a virtual Meet & Greet with Rick Doblin, Ph.D., Founder and Executive Director of MAPS, or Amy Emerson, CEO of MAPS PBC. Do you know the perfect new Major Gifts Officer, Medical Monitor, or Head of Medical Science and Safety? Let them know about opportunities at MAPS.

REFER A CANDIDATE

Donate to MAPS to Win a Trip to Lightning in a Bottle Festival
When you make a donation to MAPS using this link, you’ll be entered to win a trip for you and a friend to Lightning in a Bottle Festival! Fly to Southern California to see musical acts including Glass Animals, KAYTRANADA, GRiZ, Big Wild, CloZee, Black Coffee, Four Tet, and many more! Support MAPS and help us continue our mission of healing for all.

donate to win

Subscribe to the Psychedelic Science 2023 Email List
Mark your calendar for Psychedelic Science 2023, taking place from June 17-25, 2023! MAPS members, researchers, students, clinicians, therapists, political leaders, and psychedelic enthusiasts will gather from around the world to share the latest advances in psychedelic research. Be sure to sign up for exclusive email updates to receive news, schedules, and details about this extraordinary event.

Follow MAPS on Facebook, Twitter, Instagram, YouTube, and LinkedIn.

From all of us here at MAPS, we hope you are well and safe. Thank you for subscribing to the monthly MAPS Newsletter!

With appreciation, 

MAPS

Treating PTSD with MDMA-Assisted Therapy

Results for Phase 1 Randomized Controlled Trial of MDMA and Fear Extinction Retention in Healthy Adults Published in Psychopharmacology

Enrollment Continues in Open-Label, Phase 2, Multicenter Feasibility Study of Manualized MDMA-Assisted Therapy with an Optional fMRI Sub-Study Assessing Changes in Brain Activity in Subjects with PTSD in Europe

MDMA Therapy Training Program Update: March 2022

FDA Places Open-Label Feasibility and Safety Study of MDMA-Assisted Group Therapy for the Treatment of Posttraumatic Stress Disorder in Veterans (MPG1) On Clinical Hold

Investigator-Initiated Trials Update

Expanded Access Study Site in California Begins Screening

Support MAPS

February Giving Report: Donors Give Over $1.1 Million to Psychedelic Research and Education

Psychedelic Peer Support

Zendo Project to Attend Burning Man, Lightning In A Bottle Update

MAPS in the Media

  • The New York Times: Dr. Bronner’s, the Soap Company, Dips Into Psychedelics
  • Business Insider: 5 People Who Used Psychedelics to Treat PTSD Describe Their Experiences
  • NextAvenue: It May Be Time to Change Your Mind About Psychedelics
  • The Harvard Crimson: At Harvard, Psychedelic Drugs’ Tentative Renaissance
  • Forbes: Exclusive: MAPS Accepts $500,000 Donation From Atai Life Sciences’ Philanthropy Arm
  • Business Insider: Meet the 16 Most Influential Women Shaping the Future of Psychedelics
  • World Journal: American Phenomenon / From Psychedelics to Awakeners: Unorthodox Psychotherapy (Article in Chinese)
More MAPS in the MEDIA

Store

Beyond the Narrow Life: A Guide for Psychedelic Integration and Existential Exploration by Kile Ortigo, Ph.D.

Events

TED2022 Discovery Session: Psychedelics for Mental Health: Your Brain on Drugs 2.0, April 10-14, 2022, Vancouver, Canada

Religion and Psychedelics Forum, April 22-24, 2022, San Francisco, California

21st Annual Generations Conference, May 9-11, 2022, Salt Lake City, Utah

Polaris Insight Center: Training and Retreats, January 2022-August 2022, Online

ARISE Music Festival 2022, May 27-30, 2022, Boone, Colorado

Integrative Psychiatry Institute Psychedelic-Assisted Therapy Training, July 2022 – May 2023

Interdisciplinary Conference on Psychedelic Research 2022, September 22-24, 2022, Haarlem, Netherlands

Maine Fungi Fest, October 9, 2022, Portland, Maine

Psychedelic Science 2023, June 17-25, 2023, Denver, Colorado


Post navigation

Previous Newsletter

Newsletter: February 2022

Next Newsletter

Newsletter: April 2022

Multidisciplinary Association for Psychedelic Studies – MAPS
  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
    • Refunds & Returns
    • FAQs
    • Privacy Policy
  • Our Work
    • Psychedelic Fundamentals
    • MAPS Public Benefit Corp
    • MDMA Therapy Training
    • Zendo Project
    • Health Equity
    • Policy & Advocacy
  • Our Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • Donate
    • Host a Party
    • Participate in a Trial
    • Events
    • Resources

Newsletter Sign Up



  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn
  • Reddit
© 1986 - 2022 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. Disclaimer | Privacy Policy.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117. All Rights Reserved. Proudly powered by WordPress. Hosted by Pressable